ArticleCureus2025
Risk Factors Among HIV Seropositive Cases Attending a Tertiary Care Hospital of a North-Eastern State of India: A Hospital-Based Retrospective Cross-Sectional Study.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction Despite the relatively low HIV incidence in Assam, the region is at a critical juncture due to its strategic location as the gateway to north-eastern India and its proximity to three states with high HIV prevalence. This study, conducted from July 2022 to August 2023, aimed to assess the risk factors among HIV seropositive cases in Assam. Methods This hospital-based retrospective cross-sectional study included all HIV seropositive patients enrolled at the Integrated Counselling and Testing Centre (ICTC), Dhubri, Assam, India. The diagnosis was carried out following Strategy III of the National AIDS Control Organization (NACO), India guidelines, ensuring the thoroughness and reliability of the data. The difference in proportions was examined using a chi-square test with a p-value of less than 0.05 as significant. For identifying factors independently associated with the HIV transmission route, binary logistic regression was used. The data were analyzed using Statistical Package for the Social Sciences (SPSS) version 21 (IBM Corp., Armonk, NY). Results Out of 151 HIV seropositive patients, the majority, 133 (88.1%), were male. Most patients (95%, n=143) belonged to the young adult age group ranging from 15 to 49 years. A significant association between age of patients and gender was observed (p-value=0.002). HIV seropositivity was noted more among rural patients (n=99; 65.6%) and married female patients (p-value<0.001). The majority, 43.0% (n=65), of the patients were educated up to high school level. Injectable drug use was the leading mode of transmission (n=104; 68.9%). Route of HIV transmission was found to be significantly associated with age (p-value<0.001), gender (p-value<0.001), marital status (p-value<0.001), education (p-value<0.05), migration (p-value<0.001), and occupation (p-value<0.001). Conclusion The significant rise in new HIV infections, particularly among injectable drug users, underscores the urgent need for increased testing and awareness programs. These, along with better access to antiretroviral medication, rehabilitation programs, and stricter laws on illegal drug trafficking, could play a crucial role in controlling the spread of the disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.